Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia 8Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Neuroblastoma 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Neoplasm, Residual 2Lymphoma, Large-Cell, Anaplastic 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancoast Syndrome 1Neoplasm Metastasis 1Melanoma 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 45Prednisone 31N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 29Vincristine 28Doxorubicin 27Etoposide 22romidepsin 20Gemcitabine 18Lenalidomide 1610-propargyl-10-deazaaminopterin 16fludarabine phosphate 15Whole-Body Irradiation 15Peripheral Blood Stem Cell Transplantation 14Brentuximab Vedotin 13Azacitidine 13Mycophenolic Acid 12Dexamethasone 10Cyclosporine 10Bortezomib 10Alemtuzumab 10Rituximab 8fludarabine 7belinostat 7Methotrexate 6Cytarabine 6Busulfan 6Bendamustine Hydrochloride 6pembrolizumab 5denileukin diftitox 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Vindesine × Clear all
NCT00136565 2018-08-23

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Lymphoma Study Association

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡